These Healthcare stocks are trading higher:
-Fusion Pharmaceuticals Inc (FUSN) stock is trading at $21.10, a rise of $10.45, or 98.4%, on high volume. Fusion Pharmaceuticals Inc gets a Sentiment Score of Very Bullish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $14.64. Fusion Pharmaceuticals Inc next reports earnings on March 21.
-Scworx Corp (WORX) stock is trading at $2.75, an increase of $0.9, or 49.73%, on high volume. Scworx Corp gets a Sentiment Score of Bearish from InvestorsObserver. Scworx Corp next reports earnings on April 15.
-Enliven Therapeutics Inc (ELVN) stock is trading at $17.03, a rise of $4.39, or 34.75%, on high volume. Enliven Therapeutics Inc gets a Sentiment Score of Neutral from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $37.00.
-Actinium Pharmaceuticals Inc (ATNM) stock is trading at $8.27, an increase of $1.73, or 29.97%, on high volume. Actinium Pharmaceuticals Inc gets a Sentiment Score of Bearish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $23.72. Actinium Pharmaceuticals Inc next reports earnings on April 1.
Find the top stocks in the Healthcare Sector here.
These Healthcare stocks are trading lower:
-Eyenovia Inc (EYEN) stock is trading at $1.22, a drop of $0.31, or 20.59%, on high volume. Eyenovia Inc gets a Sentiment Score of Bearish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $9.75.
-Lantern Pharma Inc (LTRN) stock is trading at $8.01, a drop of $1.95, or 19.59%, on moderate volume. Lantern Pharma Inc gets a Sentiment Score of Bullish from InvestorsObserver and receives an average analyst recommendation of Buy with a price target of $26.00.
-Genprex Inc (GNPX) stock is trading at $3.43, a decline of $0.66, or 16.14%, on moderate volume. Genprex Inc gets a Sentiment Score of Bearish from InvestorsObserver and receives an average analyst recommendation of Buy. Genprex Inc next reports earnings on March 29.
-Acurx Pharmaceuticals Inc (ACXP) stock is trading at $2.20, a loss of $0.39, or 15.19%, on high volume. Acurx Pharmaceuticals Inc gets a Sentiment Score of Very Bearish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $12.00.
Find the top stocks in the Healthcare Sector here.
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
